Designed to protect key retinal cells, company’s Fas inhibitor drugs aim to prevent vision loss in a range of conditions. With the world buzzing about Neuralink’s latest project to restore sight to the blind, others take the view that prevention…
Browsing: All news
Category Added in a WPeMatico Campaign
Collaboration aims to empower health practitione
Coya Therapeutics is pioneering multi-pathway th
Elon Musk claims that experimental ‘Blindsight
Boosting cellular regeneration, reducing inflamm
Chai Discovery emerges with $30m in funding and
A new study considers epigenetic aging from a si
DoD-backed startup targets clinical trials of bi
Preventive health company appoints former Amazon
Ahead of Longevity Investors Conference, Matt Py